CLINICAL_TRIALS
trial_result
· 2018-08-06
Clinical Trial Update: A Dose-Escalation Study for Patients With Advanced Cancer [Phase 1]
Summary
A Phase 1 dose-escalation trial in patients with advanced cancer has completed enrollment with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-08-06